IL1B and geroderma osteodysplastica: Considering IL-1β is a major mediator of the inflammation in GO and the IGF-1 receptor pathway has recently emerged as a promising therapeutic target in GO, we evaluated the SOCS3 mRNA levels after stimulation with IL-1β (10 ng/mL) and IGF-1 (100 ng/mL).